登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C22H34I2N2 · xH2O
化学文摘社编号:
分子量:
580.33 (anhydrous basis)
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352202
MDL number:
InChI
1S/C22H34N2.2HI.H2O/c1-21-13-11-17-23(19-21)15-9-7-5-3-4-6-8-10-16-24-18-12-14-22(2)20-24;;;/h11-14,17-20H,3-10,15-16H2,1-2H3;2*1H;1H2/q+2;;;/p-2
SMILES string
O.[I-].[I-].Cc1ccc[n+](CCCCCCCCCC[n+]2cccc(C)c2)c1
InChI key
ILAREMIWZYIULF-UHFFFAOYSA-L
assay
≥98% (HPLC)
form
powder
color
white to tan
solubility
H2O: ≥10 mg/mL
storage temp.
2-8°C
Quality Level
Application
bPiDl hydrate may be used to study nicotinic receptor-mediated signaling.
Biochem/physiol Actions
bPiDI is an α6β2-specific antagonist that inhibits nicotine-evoked and endogenous dopamine release from rat striatal slices (IC50 = 150 nM, Imax = 55%). bPiDI treatment decreases nicotine self-administration, and nicotine-induced locomotor activity in rats.
bPiDl is a selective α6β2-specific nicotinic receptor antagonist
Features and Benefits
This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
商品
Sigma-Aldrich offers many products related to nicotinic acetylcholine receptors for your research needs.
Sigma-Aldrich针对您的研究需求提供了许多烟碱型乙酰胆碱受体相关的产品。
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持